A Novel Technique for Thyroplasty Type 1, With Prolene Mesh Implant

Published:October 24, 2021DOI:https://doi.org/10.1016/j.jvoice.2021.09.015



      To analyze the efficacy of a modified approach to thyroplasty type one using prolene mesh implant.

      Study Design

      Interventional study.

      Place and Duration of Study

      Combined Military Hospital Kharian, Pakistan, in Ent department, from July 2020 to Jan 2021.


      Medialization thyroplasty with prolene mesh was performed on the patients satisfying the inclusion criteria. They were analyzed objectively as well as subjectively in terms of Mean Maximum phonation time, maximum word count, and visual analog score about the quality of voice. Data analysis was done with SPSS version 20. Pre-operative and post-operative records were compared using paired sample t-test.


      A total of 39 patients underwent vocal cord medialization with prolene mesh implant. The Mean age for medialization was 41.09 + 13.37. 23 patients were females and 15 were males. 26 patients had unilateral and 13 patients had bilateral vocal dysfunction. 18 of them had vocal dysfunction due to thyroidectomy, eight had idiopathic causes and 13 had miscellaneous. The improvement in mean visual analog score was 2.87 postoperatively. Median maximum phonation time increased about five seconds postoperatively, seven seconds in males, and 4.5 seconds for females. The maximum word count increased from 11.33 preoperatively to 18.28 postoperatively. There were no major complications observed in our study.


      These results were comparable to many other studies for vocal cord medialization with different implant materials. But prolene mesh implant offers an easily available yet cost-effective alternative with similar benefits.

      Level of Evidence

      III (Treatment benefits: Non-randomized controlled cohort/follow-up study)

      Key Words

      To read this article in full you will need to make a payment


      Subscribe to Journal of Voice
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cohen SM
        • Kim J
        • Roy N
        • et al.
        The impact of laryngeal disorders on work-related dysfunction.
        Laryngoscope. 2012; 122: 1589-1594
        • Francis DO
        • Sherman AE
        • Hovis KL
        • et al.
        Life experience of patients with unilateral vocal fold paralysis.
        JAMA Otolaryngol Head Neck Surg. 2018; 144: 433-439
        • Jamal N
        • Mundi J
        • Chhetri DK.
        Higher risk of superficial injection during injection laryngoplasty in women.
        Am J Otolaryngol. 2014; 35: 159-163
        • Zhang Z
        • Chhetri DK
        • Bergeron JL.
        Effects of implant stiffness, shape, and medialization depth on the acoustic outcomes of medialization laryngoplasty.
        J Voice. 2015; 29: 230-235
        • Patel J
        • Boon M
        • Spiegel J
        • et al.
        Safety of Outpatient Type 1 Thyroplasty.
        Ear Nose Throat J. 2020; 100 (145561319894414 https://doi.org/10.1177/0145561319894414): 608S-613S
        • Desuter G
        • Henrard S
        • Van Lith-Bijl JT
        • et al.
        Shape of thyroid cartilage influences outcome of montgomery medialization thyroplasty: a gender issue.
        J Voice. 2017; 31 (245 e3- e8)
        • Kumar R
        • Banumathy N
        • Sharma P
        • et al.
        Normalisation of voice parameters in patients with unilateral vocal fold palsy: is it realistic?.
        J Laryngol Otol. 2019; 133: 1097-1102
        • Marques JAS
        • Marronnier A
        • Crampon F
        • et al.
        Early management of acute unilateral vocal fold paralysis: update of the literature.
        J Voice. 2020; 20 (PMID: 32253078 https://doi.org/10.1016/j.jvoice.2020.02.021): 30073-30074
        • Kraus DH
        • Ali MK
        • Ginsberg RJ
        • et al.
        Vocal cord medialization for unilateral paralysis associated with intrathoracic malignancies.
        J Thorac Cardiovasc Surg. 1996; 111 (discussion 9-41): 334-339
        • Desrosiers M
        • Ahmarani C
        • Bettez M.
        Precise vocal cord medialization using an adjustable laryngeal implant: a preliminary study.
        Otolaryngol Head Neck Surg. 1993; 109: 1014-1019
        • Tam S
        • Sun H
        • Sarma S
        • et al.
        Medialization thyroplasty versus injection laryngoplasty: a cost minimization analysis.
        J Otolaryngol Head Neck Surg. 2017; 46: 14
        • Hunter EJ
        • Maxfield L
        • Graetzer S.
        The effect of pulmonary function on the incidence of vocal fatigue among teachers.
        J Voice. 2019; 34: 539-546https://doi.org/10.1016/j.jvoice.2018.12.011
        • Bielamowicz S
        • Berke GS
        • Gerratt BR.
        A comparison of type I thyroplasty and arytenoid adduction.
        J Voice. 1995; 9: 466-472
        • Lundy DS
        • Casiano RR
        • Xue JW.
        Can maximum phonation time predict voice outcome after thyroplasty type I?.
        Laryngoscope. 2004; 114: 1447-1454
        • Sardesai MG
        • Merati AL
        • Hu A
        • et al.
        Impact of patient-related factors on the outcomes of office-based injection laryngoplasty.
        Laryngoscope. 2016; 126: 1806-1809
        • Sebova I
        • Ziethe A
        • Doellinger M
        • et al.
        Voice quality after thyroplasty type I using a silicone block.
        Bratisl Lek Listy. 2019; 120: 864-866
        • Watanabe K
        • Hirano A
        • Honkura Y
        • et al.
        Complications of using Gore-Tex in medialization laryngoplasty: case series and literature review.
        Eur Arch Otorhinolaryngol. 2019; 276: 255-261